View All HCPCS Sections

• M1450

  Patients who received hospice or palliative care service any time during denominator identification period or the measure assessment period

• M1451

  Patients with an active diagnosis of pervasive developmental disorder any time prior to the end of the measure assessment period

• M1452

  Patient ever had a diagnosis of dementia

• M1453

  Patients with a pre-operative visual acuity better than 20/40

• M1454

  New cied

• M1455

  Replaced or revised cied

• M1456

  Patient had a heart transplant

• M1457

  Patient had a diagnosis of asthma with any contact during the current or prior performance period or had asthma present on an active problem list any time during the performance period

• M1458

  Patient died prior to the end of the performance period

• M1459

  Patient was in hospice or receiving palliative care services at any time during the performance period

• M1460

  Diagnosis for chronic obstructive pulmonary disease, emphysema, cystic fibrosis, or acute respiratory failure

• M1461

  Patient diagnosis for chronic hepatitis c

• M1462

  Patients with clinical indications for imaging of the head

• M1463

  Documentation of at least two attempts to follow up with patient within 180 days of treatment

• M1464

  No documentation of at least two attempts to follow up with patient within 180 days of treatment

• M1465

  Patient follow up more than 180 days after treatment

• M1466

  Patient had a lumbar fusion on the same date as the discectomy/laminectomy procedure

• M1467

  Patients with an existing diagnosis of lynch syndrome

• M1468

  Patient received recommended doses of hepatitis b vaccination based on age

• M1469

  Patient has a history of hepatitis b illness or received a hepatitis b surface antigen, hepatitis b surface antibody, or total antibody to hepatitis b core antigen test with a positive result any time before or during the measurement period

• M1470

  Documentation of medical reason(s) for not administering hepatitis b vaccine (e.g., prior anaphylaxis due to the hepatitis b vaccine)

• M1471

  Documentation that patient is a medicare fee-for-service beneficiary and without additional supplementary insurance coverage for whom hep b vaccination is not reimbursable under current medicare part b coverage rules

• M1472

  Patient did not receive recommended doses of hepatitis b vaccination based on age

• M1473

  Patient situations, at any point during the denominator identification period, where the patient's functional capacity or motivation (or lack thereof) to improve may impact the accuracy of results of validated tools, such as delirium, dementia, intellectual disabilities, and pervasive and specific development disorders

• M1474

  Patients with diagnosis of dementia

• M1475

  Patients with diagnosis of huntington's disease

• M1476

  Patients with diagnosis of cognitive impairment or alzheimer's disease

• M1477

  Diagnosis of delirium

• M1478

  Psychoactive substance abuse

• M1479

  Patients whose functional capacity or motivation (or lack thereof) to improve may impact the accuracy of results of validated tools such as delirium, dementia, intellectual disabilities, and pervasive and specific development disorders

• M1480

  Patients whose functional capacity or motivation (or lack thereof) to improve may impact the accuracy of results of validated tools such as delirium, dementia, intellectual disabilities, and pervasive and specific development disorders

• M1481

  Patients receiving hospice or palliative care or who died during the measurement period

• M1482

  Positive/detectable hepatitis c virus quantitative or qualitative rna test result during the denominator identification period

• M1483

  Patients who achieve sustained virological response as identified by an hcv rna test (cpt 87522) or (cpt 87521) with a negative/undetectable hcv rna result that occurred 20 weeks to 12 months after the first positive/detectable hcv rna test result within the denominator identification period

• M1484

  Patients who did not have a repeat hcv rna labs performed for medical reasons documented by clinician (e.g., patient with limited life expectancy, delay in treatment of hcv related to treatment of hiv, hbv, hepatocellular carcinoma, decompensated cirrhosis)

• M1485

  Patients who did not achieve sustained virological response as identified by an hcv rna test (cpt 87522) or (cpt 87521) with a negative/undetectable hcv rna result that occurred 20 weeks to 12 months after the first positive/detectable hcv rna test result within the denominator identification period

• M1486

  Patients admitted to a skilled nursing facility (snf) during the period of evaluation

• M1487

  Patients in hospice in the year before or during the period of evaluation

• M1488

  Patients with a diagnosis for dementia in the year before or during the period of evaluation

• M1489

  Patient status documented

• M1490

  Patient status not documented

• M1491

  Receiving esrd mcp dialysis services by the provider during the performance period

• M1492

  Patients who did not report a fall

• M1493

  Documentation of falls not performed due to medical reasons (e.g., syncope, vertigo and related disorders, restless leg syndrome, tourette syndrome/tic disorder, back pain, concussion/mild traumatic brain injury (mtbi), cervical dystonia, or epilepsy)

• M1494

  Patients that reported a fall since the last visit

• M1495

  Patients that reported a fall occurred who had a plan of care for falls documented or patients that did not report a fall

• M1496

  Patients that had a fall who did not have a plan of care for falls documented or do not have documentation of being assessed for falls

• M1497

  Documentation of falls not performed due to medical reasons (e.g., syncope, vertigo and related disorders, restless leg syndrome, tourette syndrome/tic disorder, back pain, concussion/mild traumatic brain injury (mtbi), cervical dystonia, or epilepsy)

• M1498

  Diagnostic radiology mips value pathway

• M1499

  Interventional radiology mips value pathway

---

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/3/2026

CPT^® is a registered trademark of the American Medical Association (AMA). All rights reserved.